RecruitingNCT02107105
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer
Sponsor
M.D. Anderson Cancer Center
Enrollment
430 participants
Start Date
May 16, 2014
Study Type
OBSERVATIONAL
Conditions
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8Stage I Rectal Cancer AJCC v8Stage IV Rectal Cancer AJCC v8Stage IVA Rectal Cancer AJCC v8Stage IVB Rectal Cancer AJCC v8Stage IVC Rectal Cancer AJCC v8
Summary
This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment
- Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English
Exclusion Criteria3
- Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer
- Patient has a concurrent cancer diagnosis at the time of consent
- Patient has recurrent disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERQuality-of-Life Assessment
Complete quality of life questionnaire
OTHERQuestionnaire Administration
Complete quality of life questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02107105
Related Trials
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
NCT067460121 location
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
NCT072922983 locations
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497143 locations
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
NCT0492902814 locations
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
NCT047031011 location